HIGHLIGHTS
- who: Yun Guan from the Shanghai Medical College, Fudan University, Wulumuqi Road (M), Shanghai, China have published the research: A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol, in the Journal: (JOURNAL) of 14/09/2020
- what: The study is expected to have a similar PFS, and OS compared with the survival of standard chemoradiation reported by Stupp.
SUMMARY
The most frequently diagnosed primary brain tumor is glioblastoma (GBM). Despite definitive . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.